Global Drivers of the Breast Imaging Market

Bhvita Jani headshot
Bhvita Jani
Published: January 24, 2022 In The News

20th January 2022 – Written by Bhvita Jani – Featured on ITN online – Accurate breast cancer detection, along with a reduction in false positives and misses lesions, are forecast to be at the forefront of advancement in breast imaging.

The rising global incidence rates of breast cancer, coupled with the severe backlog of women requiring breast cancer screening appointments due to COVID-9, has reinforced the importance of women’s health and early detection of cancer.

Read full article here

You may also like
Insight
21 Jun 2023: Medical Imaging
Interventional X-ray & Mobile C-arm Equipment Markets collectively exceed $4 billion in 2022
Signify Research’s recent report “Interventional and Surgical X-ray – World – 2023” presents market dynamics, estimates, forecasts, competitive analysis and major drivers for the Interventional and Surgical X-ray market. Products included in this report are image intensifier mobile C-arm, 2D mobile C-arm, 3D mobile C-arm and O-arm, Hybrid operating rooms, General vascular angiography, Oncology / Body, Neurology, Interventional gastro, General coronary, Structural heart lab and Electrophysiology.
Arrow Right
Insight
20 Jul 2023: Medical Imaging
Fixed Digital Radiography Systems Market Set to Reach $1.3 Billion in 2023
2022 was somewhat challenging for vendors of fixed digital radiography (DR) systems, with market expansion impeded by inflationary pressure, stretched healthcare budgets and increased average selling prices.
Arrow Right
Insight
11 Mar 2024: Medical Imaging
The Medical FPD Market Reaches 78,000 units
The medical FPD market, totalling just under 78,000 units in 2022, witnessed a slight retraction in both units and revenue. The most significant decline was seen in mobile general radiography, which was attributed to a surplus during the pandemic. A decline was also seen for mammography due to a shortage of semi-conductors, inflation hikes, and a market correction following elevated investment in breast imaging systems in 2021 as budgets returned post-COVID. However, the resurgence of elective procedures, coupled with pent-up demand, contributed to the positive uptake of mobile C-arm technology.
Arrow Right